Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Efavirenz> ?p ?o. }
- Efavirenz abstract "Efavirenz (EFV, brand names Sustiva, Stocrin, Efavir etc.) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type 1.For HIV infection that has not previously been treated, the United States Department of Health and Human Services Panel onAntiretroviral Guidelines currently recommends the use of efavirenz in combination with tenofovir/emtricitabine (Truvada) as one of the preferred NNRTI-based regimens in adults and adolescents.Efavirenz is also used in combination with other antiretroviral agents as part of an expanded postexposure prophylaxis regimen to reduce the risk of HIV infection in people exposed to a significant risk (e.g. needlestick injuries, certain types of unprotected sex etc.). It is usually taken on an empty stomach at bedtime to reduce neurological and psychiatric adverse effects.Efavirenz was combined with the popular HIV medication Truvada, which consists of tenofovir and emtricitabine, all of which are reverse transcriptase inhibitors. This combination of three medications approved by the U.S. Food and Drug Administration (FDA) in July 2006 under the brand name Atripla, provides HAART in a single tablet taken once a day. It results in a simplified drug regimen for many patients.It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.".
- Efavirenz atcPrefix "J05".
- Efavirenz atcSuffix "AG03".
- Efavirenz casNumber "154598-52-4".
- Efavirenz chEBI "119486".
- Efavirenz drugbank "DB00625".
- Efavirenz fdaUniiCode "JE6H2O27P8".
- Efavirenz iupacName "(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one".
- Efavirenz pubchem "64139".
- Efavirenz thumbnail Efavirenz_skeletal.svg?width=300.
- Efavirenz wikiPageExternalLink pi_sustiva.pdf.
- Efavirenz wikiPageExternalLink www.sustiva.com.
- Efavirenz wikiPageID "1856628".
- Efavirenz wikiPageRevisionID "605451269".
- Efavirenz atcPrefix "J05".
- Efavirenz atcSuffix "AG03".
- Efavirenz c "14".
- Efavirenz casNumber "154598".
- Efavirenz chebi "119486".
- Efavirenz chembl "223228".
- Efavirenz chemspiderid "57715".
- Efavirenz cl "1".
- Efavirenz drugbank "DB00625".
- Efavirenz eliminationHalfLife "-198000.0".
- Efavirenz excretion "Renal and fecal".
- Efavirenz f "3".
- Efavirenz h "9".
- Efavirenz hasPhotoCollection Efavirenz.
- Efavirenz image "Efavirenz 3D balls 1fk9.png".
- Efavirenz inchi "1".
- Efavirenz inchikey "XPOQHMRABVBWPR-ZDUSSCGKBX".
- Efavirenz iupacName "-6".
- Efavirenz kegg "D00896".
- Efavirenz legalStatus "POM , ℞-only".
- Efavirenz medlineplus "a699004".
- Efavirenz metabolism "Hepatic".
- Efavirenz molecularWeight "315.675".
- Efavirenz n "1".
- Efavirenz niaidChemdb "32934".
- Efavirenz o "2".
- Efavirenz pdbLigand "EFZ".
- Efavirenz pregnancyCategory "D".
- Efavirenz proteinBound "99.5".
- Efavirenz pubchem "64139".
- Efavirenz routesOfAdministration "Oral".
- Efavirenz smiles "FCF".
- Efavirenz stdinchi "1".
- Efavirenz stdinchikey "XPOQHMRABVBWPR-ZDUSSCGKSA-N".
- Efavirenz tradename "Sustiva, Stocrin etc.".
- Efavirenz unii "JE6H2O27P8".
- Efavirenz verifiedrevid "458955867".
- Efavirenz watchedfields "changed".
- Efavirenz width "150".
- Efavirenz subject Category:Alkynes.
- Efavirenz subject Category:Benzoxazines.
- Efavirenz subject Category:Bristol-Myers_Squibb.
- Efavirenz subject Category:Carbamates.
- Efavirenz subject Category:Cyclopropanes.
- Efavirenz subject Category:Depressogenics.
- Efavirenz subject Category:Non-nucleoside_reverse_transcriptase_inhibitors.
- Efavirenz subject Category:Organochlorides.
- Efavirenz subject Category:Organofluorides.
- Efavirenz subject Category:World_Health_Organization_essential_medicines.
- Efavirenz type Abstraction100002137.
- Efavirenz type Acetylene114600742.
- Efavirenz type AliphaticCompound114601294.
- Efavirenz type Alkynes.
- Efavirenz type Carbamate114792281.
- Efavirenz type Carbamates.
- Efavirenz type Chemical114806838.
- Efavirenz type Cognition100023271.
- Efavirenz type Compound114818238.
- Efavirenz type Content105809192.
- Efavirenz type Discipline105996646.
- Efavirenz type KnowledgeDomain105999266.
- Efavirenz type LifeScience106037298.
- Efavirenz type Material114580897.
- Efavirenz type Matter100020827.
- Efavirenz type MedicalScience106045562.
- Efavirenz type Medicine106043075.
- Efavirenz type NaturalScience106000400.
- Efavirenz type OrganicCompound114727670.
- Efavirenz type Part113809207.
- Efavirenz type PhysicalEntity100001930.
- Efavirenz type PsychologicalFeature100023100.
- Efavirenz type Relation100031921.
- Efavirenz type Salt115010703.
- Efavirenz type Science105999797.
- Efavirenz type Substance100019613.
- Efavirenz type WorldHealthOrganizationEssentialMedicines.
- Efavirenz type Drug.
- Efavirenz type DrugProduct.
- Efavirenz type FunctionalSubstance.
- Efavirenz comment "Efavirenz (EFV, brand names Sustiva, Stocrin, Efavir etc.) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type 1.For HIV infection that has not previously been treated, the United States Department of Health and Human Services Panel onAntiretroviral Guidelines currently recommends the use of efavirenz in combination with tenofovir/emtricitabine (Truvada) as one of the preferred NNRTI-based regimens in adults and adolescents.Efavirenz is also used in combination with other antiretroviral agents as part of an expanded postexposure prophylaxis regimen to reduce the risk of HIV infection in people exposed to a significant risk (e.g. ".
- Efavirenz label "Efavirenz".
- Efavirenz label "Efavirenz".
- Efavirenz label "Efavirenz".
- Efavirenz label "Efavirenz".
- Efavirenz label "Efavirenz".
- Efavirenz label "Efawirenz".